Revenue

A fierce bidding war for Avadel Pharmaceuticals reveals the high value of its key drug, as filings from giants like State Street highlight M&A transparency.

After a financial tightrope walk, Actelis Networks is back in Nasdaq's good graces. But the real story is its mission to secure our future's IoT.

Wealth Enhancement's $2.2B deal for L.M. Kohn isn't just another acquisition. It signals a tech-fueled consolidation wave reshaping financial advice.

A new report on AI in the energy sector reveals a critical truth for medicine: general-purpose AI is not ready for high-stakes decisions without human experts.

Eli Lilly's groundbreaking leukemia drug data signals a major market shift, promising better patient outcomes and fortifying its long-term growth strategy.

A decade-long initiative by Sands China has funneled MOP 119.4B into local businesses, revealing a strategic blueprint for economic diversification.

AskBio's gene therapies for Parkinson's and heart failure have received Japan's SAKIGAKE designation, promising a faster path to patients.

Accenture is training 30,000 pros on Anthropic's Claude AI, tackling the biggest barrier to enterprise AI: moving from costly experiments to real value.

Tabletop giant Asmodee is raising €320M. We decode the complex financial strategy and reveal how it fortifies its vast global supply chain.

One agency's breakout year reveals a critical lesson: strategic AI adoption is no longer optional. Discover the framework for moving beyond hype to ROI.

Aviz Networks just launched a certified SONiC distribution, aiming to break down the barriers of complexity and support that have kept open networking on the sidelines.

A new patent for its lead cancer drug in Japan is more than a legal win; it's a strategic move to secure a future market into the 2040s.

Facing a fiscal crunch, San Diego County's move to a cloud-based budget system offers a model for data-driven efficiency and public service reform.

JFB Construction's CEO just invested $100k of his own money in company stock. We dive into the projects and market trends fueling this bold move.

Spectral Capital projects massive growth via acquisitions and quantum tech, but its ambitious NASDAQ plan faces significant financial and execution hurdles.

PERIOD. appoints Jennifer Herrera as its new ED. How will her background in national advocacy and grassroots organizing reshape the fight for menstrual equity?

Animal health giant Elanco is restructuring its global footprint, betting its future on a U.S.-centric innovation pipeline and blockbuster pet health drugs.

OutSystems' #1 G2 ranking isn't just an award; it signals a seismic shift where AI-powered low-code and user satisfaction are the new currencies.

Groundbreaking lymphoma data and a strategic acquisition position Natera to dominate the liquid biopsy market, challenging old standards and creating new value.

Vancouver's SimplyAsk.ai and Mexican telecom giant Axtel partner to tackle AI's high failure rate, aiming to unlock a multi-billion dollar market.